Ryan T.Drzemiecki

Associate

Pittsburgh + 1.412.394.7256

Connect:

Share

Ryan Drzemiecki focuses his practice on domestic and cross-border M&A as well as general transactional and corporate matters. He counsels clients on a variety of general corporate governance matters, including fiduciary duties, shareholder engagement, and takeover defense. As a corollary to his main practice, Ryan has developed experience with post-transactional matters, including indemnification claims and purchase price adjustments.

Ryan has experience representing private and public companies and private equity firms engaged in acquisitions, divestitures, joint ventures, corporate restructuring, and related commercial transactions. He has advised domestic and international clients in a broad range of industries, including private equity, energy, mining, manufacturing, metals, cosmetics, and packaging.

Experience

  • Wabtec and GE Transportation merge in $11.1 billion transactionJones Day advised Wabtec Corporation in a Reverse Morris Trust merger with GE Transportation, valued at $11.1 billion.
  • Shiseido acquires Drunk Elephant™ for $845 millionJones Day advised Shiseido Americas Corporation in its $845 million acquisition of Drunk Elephant™.
  • Total sells Atotech to The Carlyle Group for $3.2 billionJones Day advised Total in the $3.2 billion sale of specialty chemical affiliate Atotech B.V., a global manufacturer of high technology plating solutions, to The Carlyle Group.
  • Calgon Carbon acquired by Kuraray for $1.3 billionJones Day advised Calgon Carbon Corporation (NYSE:CCC) in its $1.3 billion all-cash acquisition by Kuraray Co., Ltd. (TSE:3405).
  • Bridgestone attempts $947 million all-cash tender offer for Pep BoysJones Day represented Bridgestone Americas, Inc. in its proposed acquisition, through its wholly owned subsidiary Bridgestone Retail Operations, LLC ("BSRO"), of The Pep Boys - Manny, Moe & Jack, in an all-cash tender offer of $947 million.
  • Shiseido Americas acquires Gurwitch ProductsJones Day advised Shiseido Americas Corporation ("Shiseido Americas"), a subsidiary of Shiseido Co., Ltd. (Tokyo Stock Exchange, First Section: 4911), a leading global cosmetics company, in connection with the acquisition of Gurwitch Products, LLC ("Gurwitch") from Alticor, Inc.
  • Tekni-Plex acquires Lameplast SpAJones Day acted as co-counsel to Tekni-Plex, Inc. in its acquisition of Lameplast SpA, an Italian healthcare packaging company, from Milan-based private equity firm Aksìa Group.
  • Curavi acquires TripleCareJones Day advised University of Pittsburgh Medical Center ("UPMC) and Curavi, in the acquisition by subsidiary Curavi of TripleCare, a Long Island City, New York-based provider of telemedicine solutions for the post-acute, long-term care industry, including skilled nursing facilities.
  • NEP Group acquired by Carlyle Global PartnersJones Day advised the NEP Group, Inc., a Pittsburgh-based global leader in outsourced technical production for producers of live sports, entertainment, music and corporate events, in connection with the acquisition by Carlyle Global Partners of a majority stake in NEP Group.
  • Riverside sells BeneSysJones Day advised The Riverside Company in connection with its sale of BeneSys, a provider of third-party administration (TPA) services for employee healthcare and pension benefit programs for Taft-Hartley multi-employer plans.
  • Tekni-Plex acquires Commodore Plastics and Commodore TechnologyJones Day advised Tekni-Plex, Inc., a portfolio company of private equity fund Genstar Capital, in connection with the acquisition of substantially all of the assets of Commodore Plastics and Commodore Technology, a family owned industrial business specializing in the manufacture of foam and plastic packaging.
  • Tekni-Plex acquires Dunn IndustriesJones Day advised Tekni-Plex, Inc., a portfolio company of private equity fund Genstar Capital, in connection with its acquisition of Dunn Industries, Inc., a family owned industrial company specializing in the manufacture of extrusion tubing for the medical device market.
  • Allegheny Technologies and Tsingshan form innovative stainless steel joint ventureJones Day advised Allegheny Technologies (ATI), a global manufacturer of advanced specialty materials, in connection with the formation of a 50/50 joint venture with an affiliate of Tsingshan Group.
  • Riverside acquires CarePatrolJones Day represented The Riverside Company in connection with the add-on acquisition and related financing to the ComForCare platform of CarePatrol, a senior living advisory and placement services franchisor.
  • Amzak Capital Management acquires StampTechJones Day represented Amzak Capital Management, LLC in connection with its acquisition of StampTech, Inc., a provider of fabricated sheet metal and metal stamping.
  • Groupe Solmax acquires GSE Environmental from Littlejohn & Co. and Strategic Value PartnersJones Day acted as international counsel to Groupe Solmax, Inc., a Canadian-based industry leader in the production of high-quality polyethylene geomembranes for industrial and environmental applications, in connection with the acquisition and related financing of GSE Environmental, a global industry leader in the production of polyethylene geomembranes for industrial and environmental applications, from Littlejohn & Co. and Strategic Value Partners.
  • Macquarie Capital sold controlling stake in Utility Service Partners to HomeServe USAJones Day advised Macquarie Capital in the sale of its controlling stake in Utility Service Partners, Inc., a nationwide provider of utility line warranties, to HomeServe USA.
  • Tekni-Plex acquires Sancap Liner TechnologyJones Day advised Tekni-Plex, Inc., a portfolio company of private equity fund American Securities, in connection with its acquisition of substantially all of the assets of Lexington Abrasives, Inc., Sancap Abrasives, Inc., and Sancap Liner Technology, Inc. (collectively "Sancap").
  • Shiseido Americas sells its RéVive Skincare brand to affiliate of Tengram Capital PartnersJones Day advised Shiseido Americas Corporation, a subsidiary of Shiseido Co., Ltd., a leading global cosmetics company, in connection with the sale of its RéVive Skincare brand to an affiliate of Tengram Capital Partners.
  • Riverside invests in ComForCare Health Care HoldingsJones Day represented The Riverside Company in connection with its investment in and related financing of ComForCare Health Care Holdings, LLC, the franchisor of ComForCare Home Care and At Your Side Home Care home care agencies.
  • Riverside sells YourMembership.comJones Day represented The Riverside Company in connection with its sale of YourMembership.com, a SaaS-based membership management software provider.
  • Riverside acquires CastlewoodJones Day represented The Riverside Company in connection with its acquisition of Castlewood Treatment Centers, an eating disorder treatment provider with clinics in California, Missouri, and Alabama.
  • Riverside acquires Blue Moon Estate SalesJones Day represented The Riverside Company in connection with its acquisition of Blue Moon Estate Sales, LLC, the leading estate sales franchise in the U.S.
  • Tekni-Plex acquires MMC Packaging Equipment Ltd.Jones Day was U.S. counsel to Tekni-Plex, Inc. with respect to trade compliance and anti-bribery/anti-corruption matters in the acquisition of automation equipment solutions manufacturer MMC Packaging Equipment Ltd.
  • Riverside sells IDOC to Investors Management CorporationJones Day advised The Riverside Company in connection with its sale of Independent Doctors of Optometric Care (IDOC), a large privately held alliance of independent doctors of optometry, to Investors Management Corporation.
    • View All
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.